Immunoablation and Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: The Ultimate Test for the Autoimmune Pathogenesis Hypothesis

von Leis, A. Arturo, Ross, Mark A., Verheijde, Joseph L., Leis, Jose F.
Veröffentlicht in Front Neurol (2016)

Addition of GM-CSF Does Not Improve Response to Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab and Rituximab

von Zent, Clive S., Wu, Wenting, Bowen, Deborah A., Hanson, Curtis A., Pettinger, Adam M., Shanafelt, Tait D., Kay, Neil E., Leis, Jose F., Call, Timothy G.
Veröffentlicht in Leuk Lymphoma (2012)

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia

von Kay, Neil E., Strati, Paolo, LaPlant, Betsy R., Leis, Jose F., Nikcevich, Daniel, Call, Timothy G., Pettinger, Adam M., Lesnick, Connie E., Hanson, Curtis A., Shanafelt, Tait D.
Veröffentlicht in Oncotarget (2016)

Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes with Bendamustine to Induce CLL Apoptosis

von Ding, Wei, Shanafelt, Tait D., Lesnick, Connie E., Erlichman, Charles, Leis, Jose F., Secreto, Charla, Sassoon, Traci R., Call, Timothy G., Bowen, Deborah A., Conte, Michael, Kumar, Shaji, Kay, Neil E.
Veröffentlicht 2013

Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated CLL

von Shanafelt, Tait, Lanasa, Mark C., Call, Timothy G, Beaven, Anne W., Leis, Jose F., LaPlant, Betsy, Bowen, Deborah, Conte, Michael, Jelinek, Diane F., Hanson, Curtis A., Kay, Neil E., Zent, Clive S.
Veröffentlicht 2013

Hematologist/Oncologist Disease-Specific Expertise and Survival: Lessons from Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL)

von Shanafelt, Tait D., Kay, Neil E., Rabe, Kari G., Inwards, David J., Zent, Clive S., Leis, Jose F., Schwager, Susan M., Thompson, Carrie A., Bowen, Deborah A., Witzig, Thomas E., Slager, Susan L., Call, Timothy G.
Veröffentlicht 2011

Diffuse Large B-Cell Lymphoma (Richter Syndrome) in Patients with Chronic Lymphocytic Leukaemia: A Cohort Study of Newly Diagnosed Patients

von Parikh, Sameer A., Rabe, Kari G., Call, Timothy G., Zent, Clive S., Habermann, Thomas M., Ding, Wei, Leis, Jose F., Schwager, Susan M., Hanson, Curtis A., Macon, William R., Kay, Neil E., Slager, Susan L., Shanafelt, Tait D.
Veröffentlicht 2013

The efficacy of ibrutinib in the treatment of Richter syndrome

von Tsang, Mazie, Shanafelt, Tait D., Call, Timothy G., Ding, Wei, Chanan-Khan, Asher, Leis, Jose F., Nowakowski, Grzegorz S., Bowen, Deborah, Conte, Michael, Schwager, Susan M., Slager, Susan L., Kay, Neil E., Hanson, Curtis A., Parikh, Sameer A.
Veröffentlicht in Blood (2015)

Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma

von Parikh, Sameer A., Habermann, Thomas M., Chaffee, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Macon, William R., Schwager, Susan M., Ristow, Kay M., Porrata, Luis F., Kay, Neil E., Slager, Susan L., Shanafelt, Tait D.
Veröffentlicht in Am J Hematol (2015)

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

von Jain, Tania, Kunze, Katie L., Temkit, M’hamed, Partain, Daniel K., Patnaik, Mrinal S., Slack, James L., Khera, Nandita, Hogan, William J., Roy, Vivek, Noel, Pierre, Leis, Jose F., Sproat, Lisa Z., Fauble, Veena, Mesa, Ruben A., Palmer, Jeanne
Veröffentlicht in Bone Marrow Transplant (2018)

Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL)

von Shanafelt, Tait D., Call, Tim G., Zent, Clive S., Leis, Jose F., LaPlant, Betsy, Bowen, Deborah A., Roos, Michelle, Laumann, Kristina, Ghosh, Asish K., Lesnick, Connie, Lee, Mao-Jung, Yang, Chung S., Jelinek, Diane F., Erlichman, Charles, Kay, Neil E.
Veröffentlicht 2012

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

von Wang, Yucai, Tschautscher, Marcella A., Rabe, Kari G., Call, Timothy G., Leis, Jose F., Kenderian, Saad S., Kay, Neil E., Muchtar, Eli, Van Dyke, Daniel L., Koehler, Amber B., Schwager, Susan M., Slager, Susan L., Parikh, Sameer A., Ding, Wei
Veröffentlicht in Haematologica (2020)

Incidence of Chronic Lymphocytic Leukemia and High Count Monoclonal B-cell Lymphocytosis using the 2008 Guidelines

von Call, Timothy G., Norman, Aaron D., Hanson, Curtis A., Achenbach, Sara J., Kay, Neil E., Zent, Clive S., Ding, Wei, Leis, Jose F., Cerhan, James R., Rabe, Kari G., Vachon, Celine M., Hallberg, Emily J., Shanafelt, Tait D., Slager, Susan L.
Veröffentlicht 2014

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy

von Sinha, Sutapa, Boysen, Justin C., Chaffee, Kari G., Kabat, Brian F., Slager, Susan L., Parikh, Sameer A., Secreto, Charla R., Call, Tim, Shanafelt, Tait D., Leis, Jose F., Warner, Steven L., Bearss, David J., Ghosh, Asish K., Kay, Neil E.
Veröffentlicht in Oncotarget (2018)

Cyclophosphamide, bortezomib and dexamethasone (CyBorD) induction for newly diagnosed multiple myeloma: High response rates in a phase II clinical trial

von Reeder, Craig B., Reece, Donna E., Kukreti, Vishal, Chen, Christine, Trudel, Suzanne, Hentz, Joseph, Noble, Brie, Pirooz, Nicholas A., Spong, Jacy E., Piza, Jesus G., Zepeda, Victor H. Jimenez, Mikhael, Joseph R., Leis, Jose F., Bergsagel, P. Leif, Fonseca, Rafael, Stewart, A. Keith
Veröffentlicht 2009

Hypogammaglobulinemia in Newly Diagnosed Chronic Lymphocytic Leukemia: Natural History, Clinical Correlates and Outcomes

von Parikh, Sameer A., Leis, Jose F., Chaffee, Kari G., Call, Timothy G., Hanson, Curtis A., Ding, Wei, Chanan-Khan, Asher A., Bowen, Deborah, Conte, Michael, Schwager, Susan, Slager, Susan L., Van Dyke, Daniel L., Jelinek, Diane F., Kay, Neil E., Shanafelt, Tait D.
Veröffentlicht in Cancer (2015)

Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis

von Jain, Tania, Kunze, Katie L., Mountjoy, Luke, Partain, Daniel K., Kosiorek, Heidi, Khera, Nandita, Hogan, William J., Roy, Vivek, Slack, James L., Noel, Pierre, Fauble, Veena D. S., Leis, Jose F., Sproat, Lisa, Tefferi, Ayalew, Patnaik, Mrinal M., Mesa, Ruben A., Palmer, Jeanne
Veröffentlicht in Blood Cancer J (2020)

Akt inhibitor MK-2206 in combination with Bendamustine and Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results from the N1087 Alliance Study

von Larsen, Jeremy T., Shanafelt, Tait D., Leis, Jose F., LaPlant, Betsy, Call, Tim, Pettinger, Adam, Hanson, Curtis, Erlichman, Charles, Habermann, Thomas Matthew, Reeder, Craig, Nikcevich, Daniel, Bowen, Deborah, Conte, Michael, Boysen, Justin, Secreto, Charla, Lesnick, Connie, Tschumper, Renee, Jelinek, Diane, Kay, Neil E., Ding, Wei
Veröffentlicht in Am J Hematol (2017)

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

von Parikh, Sameer A., Chaffee, Kari G., Larson, Melissa C., Hampel, Paul J., Call, Timothy G., Ding, Wei, Kenderian, Saad S., Leis, Jose F., Chanan-Khan, Asher A., Conte, Michael J., Bowen, Deborah, Schwager, Susan M., Slager, Susan L., Hanson, Curtis A., Kay, Neil E., Shanafelt, Tait D.
Veröffentlicht in Haematologica (2018)

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

von Hampel, Paul J., Ding, Wei, Call, Timothy G., Rabe, Kari G., Kenderian, Saad S., Witzig, Thomas E., Muchtar, Eli, Leis, Jose F., Chanan-Khan, Asher A., Koehler, Amber B., Fonder, Amie L., Schwager, Susan M., Slager, Susan L., Shanafelt, Tait D., Kay, Neil E., Parikh, Sameer A.
Veröffentlicht in Leuk Lymphoma (2019)